Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1

NCT05585307 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT05585307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05585307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1
Lead sponsor
Gilead Sciences
Phase
Phase 1
Overall status
Completed
Start date
October 26, 2022
Completion date
March 18, 2024
Enrollment
49 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection